HOME >> BIOLOGY >> NEWS
2nd Annual CDB Symposium: Developmental Remodeling (March 29 - 31, 2004; Kobe, Japan)

The RIKEN Center for Developmental Biology (CDB) was established in April 2000 in Kobe, Japan to promote research into the fundamental mechanisms of animal development and regeneration. To keep up with advances and identify future directions in these rapidly evolving fields, the CDB inaugurated a program of annual symposia covering diverse aspects of developmental biology and regeneration and aimed at promoting the free and timely exchange of research achievements. The first annual CDB Symposium, "The Origin and Formation of Multicellular Systems," was convened in March 2003. We are pleased to announce that the second symposium in the series will focus on the theme of "Developmental Remodeling," and will be held from March 29 to 31, 2004 in the CDB auditorium.

This symposium will cover a broad range of subjects relating to the plasticity of biological systems, and will feature talks by a number of internationally distinguished invitees and speakers selected from amongst the symposium attendees. The initial sessions will be devoted to discussion of the molecular mechanisms of gene regulation at the level of chromatin organization, and experimental approaches to the recapitulation of pluripotency in somatic nuclei. These will be followed by sessions on the plasticity of cells and tissues in morphogenetic processes in development and regeneration following injury. The final session will address organismal remodeling during ontogeny (i.e., metamorphosis) and evolution. It is hoped that the broad scope of the presentations and disciplines covered will stimulate fruitful discussion and yield fresh new insights into the stability and plasticity of biological systems.

Attendance to the CDB Symposium will be limited to approximately 120 general attendees, and all those interested in participating are asked to submit an application for review by the organizing committee. Applicants for attendance are encouraged to submit poster abstracts with their appli
'"/>

Contact: Doug Sipp
sipp@cdb.riken.jp
81-783-063-043
RIKEN Center for Developmental Biology
11-Dec-2003


Page: 1 2

Related biology news :

1. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
2. Popular Science announces Third Annual Brilliant 10
3. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
4. ESA 89th Annual Meeting
5. Organization for Human Brain Mapping 2004 Annual Meeting
6. Annual Chemical Biology Symposium at Yale May 14, 2004
7. AIUM to honor ultrasound pioneers at its 2004 Annual Convention
8. National Academies advisory: NAS Annual Meeting April 17-20
9. Society of Nuclear Medicines 51st Annual Meeting June 19-23, 2004
10. Annual bioethics forum to explore genetic testing
11. Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Annual CDB Symposium Developmental Remodeling March Kobe Japan

(Date:7/23/2014)... The drought that has the entire country in its grip ... may also be responsible for the proliferation of a heat-loving ... rivers and hot springs, which the drought has made warmer ... died of an infection caused by this parasite after swimming ... the nose of an individual and travels to the brain. ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
(Date:7/23/2014)... 2014 BioCatch, the global leader ... it has been named in Gartner,s Market Guide for ... Gartner,s well-known Magic Quadrant for Web Fraud Detection. ... of several vendors to deliver passive biometric analysis and ... standard feature of at least 30% of one-stop fraud ...
Breaking Biology News(10 mins):Diseases of another kind 2Protein evolution follows a modular principle 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... BRUSSELS , July 23, 2014 regulated ... its research and development pipeline with positive topline ... brivaracetam . This study was designed to evaluate ... (100 and 200 mg/day, without titration) compared to ... patients with partial-onset seizures, not fully controlled despite ...
(Date:7/23/2014)... Calif. , July 23, 2014  Sofinnova Ventures, ... firm, today announced the closing of Sofinnova Venture Partners ... and in excess of the initial fund target of ... entrepreneurs build successful biotechnology companies. Consistent with recent funds, ... promising later stage clinical programs, along with select investments ...
(Date:7/23/2014)... 23, 2014 OncLive® is pleased ... has joined its Strategic Alliance Partnership program. ... program, UNC Lineberger will have the opportunity to ... of its cutting-edge research initiatives, community-directed cancer prevention ... will work with OncLive to educate their peers ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: